National manufacturer of
immunobiological products in Russia
En
National manufacturer of
immunobiological products in Russia

Influenza vaccine (inactivated) SOVIGRIPP®

Trade name

SOVIGRIPP ®

Dosage form

Solution for intramuscular injection

Shelf life

1 year old

Manufacturer

NPO Microgen, 105 Novorossiyskaya str., Ufa, Republic of Bashkortostan, 450014 Russia

Presentation

solution for intramuscular injection, 0.5 ml (1 dose) per ampule or disposable syringes with needles and protective caps. 10 ampoules in each cardboard box with a package insert and an ampoule cutter. 5 ampoules in each dose tray. 2 PVC blister in each cardboard package with a package insert and an ampoule cutter. If the ampoule has a score line, a ring or a dot, an ampoule cutter is not inserted. 1 syringe in each PVC blister. 1 PVC blister in each cardboard package with a package insert.

Ingredients

1 dose (0.5 ml) contains:

Vaccine with preservative
  • hemagglutinin of influenza virus subtype A(H1N1) - 5 µg;
  • hemagglutinin of influenza virus subtype А(H3N2) - 5 µg;
  • hemagglutinin of influenza virus type B - 11 µg;
  • SOVIDON adjuvant - 500 µg;
  • preservative – thiomersal (merthiolate) - (50.0 ± 7.5) µg;
  • phosphate buffered saline - up to 0.5 ml.
Vaccine without preservative
  • hemagglutinin of influenza virus subtype A(H1N1) - 5 µg;
  • hemagglutinin of influenza virus subtype А(H3N2) - 5 µg;
  • hemagglutinin of influenza virus type B - 11 µg;
  • SOVIDON adjuvant - 500 µg;
  • phosphate buffered saline - up to 0.5 ml.

Note.

Composition of phosphate buffered saline #1 (for the preparation without preservative): 9 g of sodium chloride, 1.5 g of sodium hydrogen phosphate, 0,12-0,14 g of potassium dihydrogen, water for injection up to 1 liter.
Composition of phosphate buffered saline #2 (for the preparation with preservative): 9 g of sodium chloride, 1.5 g of sodium hydrogen phosphate, 0,12-0,14 g of potassium dihydrogen, 0.85 ml of 1% thiomersal (merthiolate) solution, water for injection up to 1 liter.
Description. Colorless or yellowish transparent liquid. Immunobiological properties. The vaccine develops high specific immunity against seasonal flu.

Indications

Active annual preventive immunization against seasonal influenza in people aged 18 and above

The vaccine is particularly indicated
1. To persons with high risk of disease or complications if infected with influenza:
  • people over 60 years old;
  • people with frequent episodes of acute respiratory viral infections
  • people with chronic medical conditions, including diseases and malformations of the cardiovascular, respiratory and central nervous system, chronic kidney diseases, metabolic diseases, diabetes, chronic anemia, allergic diseases (except allergy to chicken proteins); congenital or acquired immunodeficiency, including infected with human immunodeficiency virus.
2. People who due to their educational or professional activities have a high risk of catching influenza or infecting other people;
  • students over 18 years old;
  • healthcare workers;
  • workers of the social, management, education, service, catering, transportation, trade spheres;
  • military men, policemen.